The import of penicillins or streptomycins in dosage forms to France is projected to exhibit a steady decline from 2024 to 2028. In 2024, imports are forecasted at 3.2535 million kilograms, decreasing gradually to 3.2004 million kilograms by 2028. This trend reflects a consistent annual reduction in import volumes, indicative of diminishing demand or increased self-sufficiency in production. As of 2023, the exact import quantities are not specified, but the declining trend is evident over the forecast period.
Future trends to watch for include potential shifts in domestic production capacities, changes in healthcare demand, and regulatory impacts on pharmaceutical imports. Monitoring these factors could provide insights into further fluctuations in import volumes.
